Kurs & Likviditet
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
9.2.2021 08:22:03 CET | Demant A/S | Notice to general meeting
To the shareholders of Demant A/S |
9 February 2021 |
Notice is hereby given of the Annual General Meeting of Demant A/S to be held on:
Friday, 5 March 2021 at 3:00pm CET
Important notice regarding coronavirus
As a consequence of the situation with the coronavirus, the AGM will be held as a fully electronic general meeting without the possibility of physical attendance.
The fully electronic general meeting will take place in accordance with the Danish Executive Order (in Danish: “bekendtgørelse”) no. 2240 of 29 December 2020, which allows companies to conduct a fully electronic general meeting, regardless that this has not been approved in advance by the shareholders and included in the Company's Articles of Association.
As a consequence hereof, there will be no possibility for the shareholders' to attend in person at the general meeting. The shareholders will instead be able to attend electronically.
Please see below in of this notice for further information regarding attendendance the general meeting, including electronically, by using the opportunity to vote by post and to provide proxy to the Board of Directors.
Agenda
In accordance with Article 8.2 of the Articles of Association, the agenda is as follows:
1. The Board of Directors’ report on the Company’s activities in the past year.
The Board of Directors recommends that the report be adopted.
2. Presentation for approval of the audited Annual Report 2020, including the consolidated financial statements.
The Board of Directors recommends that the Annual Report 2020 be approved.
3. Resolution on the appropriation of profit or payment of loss according to the approved Annual Report 2020.
The Board of Directors proposes that the profit of DKK 789 million be transferred to the Company's reserves to the effect that no dividend be paid.
4. Presentation of and indicative vote on the remuneration report for 2020.
5. Approval of remuneration for the Board of Directors for the current financial year.
The Board of Directors recommends that the proposed remuneration be approved.
6. Election of members to the Board of Directors.
Under Article 11.2 of the Articles of Association, board members elected by the AGM are elected for one-year terms. At the 2021 AGM, Niels B. Christiansen, Niels Jacobsen and Anja Madsen stand for re-election, whereas Benedikte Leroy and Lars Rasmussen do not stand for re-election. The board proposes that Sisse Fjelsted Rasmussen and Kristian Villumsen be elected new members of the board.
7. Election of auditor.
The Board of Directors proposes that Deloitte Statsautoriseret Revisionspartnerselskab be re-elected.
8. Any proposals from the Board of Directors or shareholders.
The Board of Directors has submitted the following proposals:
8a) Reduction of the Company’s share capital
8b) Authorisation to the Board of Directors to let the Company acquire own shares
8c) Proposal to add a new item to the agenda for the annual general meeting in Article 8.2 of the Articles of Association regarding presentation of and indicative vote on the remuneration report
8d) Proposal that the publication of information in accordance with the applicable stock exchange legislation, including Company announcements, shall be made in English and amending the Articles of Association accordingly
8e) Authorisation to hold fully electronic general meetings
8f) Authorisation for increase of share capital
8g) Authority to the chairman of the Annual General Meeting
9. Any other business
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 | Other contacts: René Schneider, CFO Mathias Holten Møller, Head of Investor Relations Christian Lange, Investor Relations Officer Trine Kromann-Mikkelsen, VP Corporate Communications and Relations |
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.